0
0
New Delhi, April 16: Fortis Healthcare announced the launch of the Fortis Institute of Genomic Medicine yesterday, establishing a dedicated centre focused on leveraging genetic insights for personalized healthcare. The new institute aims to enhance the diagnosis, treatment, and early detection of diseases like cancer, heart problems, and neurological disorders through genomic medicine.
The launch, which took place on Tuesday, April 15th, brings together a multidisciplinary team of doctors and experts spanning fields such as oncology, cardiology, neurology, pathology, and genomics. According to a statement released by Fortis Healthcare, the institute will concentrate on the key areas of onco-genomics, cardio-genomics, and neuro-genomics. By decoding the specific genetic markers associated with diseases, the institute plans to offer more targeted and effective treatments.
Anil Vinayak, Group Chief Operating Officer at Fortis Healthcare, highlighted the transformative potential of this approach. “This approach will not only enable early detection and risk assessment but also significantly enhance treatment accuracy, especially in complex cases such as rare neurological conditions, congenital heart disease, and aggressive cancers,” he stated. “By integrating genomics into our core offerings, we are enhancing our ability to deliver personalised, data-driven care while redefining the standards of health care innovation.”
Speaking at the launch event, Yash Rawat, Facility Director at Fortis Memorial Research Institute (FMRI), Gurugram, emphasized the crucial role genomics can play in addressing India’s increasing burden of non-communicable diseases. “Whether it’s a child with unexplained anaemia or a woman with a family history of breast cancer, genomics helps in personalising treatment approaches, improving outcomes, and reducing risks,” Rawat explained.
The hospital further stated that the application of genomics will empower doctors to gain a deeper understanding of a patient’s genetic predispositions, leading to more precise treatments and facilitating earlier diagnosis for individuals with rare or inherited health conditions.
Disclaimer: This news article is based on information provided in a press release dated April 15th. It summarizes the key points regarding the launch of the Fortis Institute of Genomic Medicine.
